Stock Price Movement and Market Context
On 11 Dec 2025, Chemfab Alkalis recorded its lowest price in the last 52 weeks at Rs.451.6. This follows a sequence of four consecutive days of price declines, although the stock showed a modest gain today, outperforming its sector by 0.67%. Despite this slight uptick, the share price remains below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a persistent bearish trend.
In contrast, the broader market has demonstrated resilience. The Sensex opened flat but moved into positive territory, trading at 84,500.21 points, up 0.13% on the day and just 1.96% shy of its 52-week high of 86,159.02. Mid-cap stocks led the market gains with the BSE Mid Cap index rising by 0.17%. This divergence highlights Chemfab Alkalis’ underperformance relative to the overall market environment.
Long-Term Price Performance
Over the past year, Chemfab Alkalis has experienced a substantial decline in its stock price, with a total return of -59.06%. This contrasts with the Sensex’s positive return of 3.73% during the same period, underscoring the stock’s relative weakness. The 52-week high for Chemfab Alkalis was Rs.1,174.55, illustrating the extent of the price contraction from its peak.
Crushing the market! This Small Cap from Aerospace & Defense just earned its spot in our Top 1% with impressive gains. Don't let this opportunity slip through your hands.
- - Recent Top 1% qualifier
- - Impressive market performance
- - Sector leader
See What's Driving the Rally →
Financial Performance and Profitability Trends
Chemfab Alkalis’ financial results have reflected ongoing pressures. The company reported a decline in net sales by 16.36% in the most recent quarter, continuing a trend of negative results over the last ten quarters. Quarterly net sales stood at Rs.76.56 crores, down 12.3% compared to the previous four-quarter average.
Profit before tax excluding other income (PBT less OI) registered a loss of Rs.3.09 crores, representing a fall of 316.1% relative to the prior four-quarter average. Similarly, the net profit after tax (PAT) was negative at Rs.2.01 crores, down 274.8% from the average of the preceding four quarters. These figures illustrate the challenges the company has faced in maintaining profitability.
Valuation and Capital Efficiency
The company’s return on capital employed (ROCE) is reported at 1.8%, which is relatively low given its valuation metrics. The enterprise value to capital employed ratio stands at 1.6, indicating a valuation premium compared to peer averages historically. This suggests that the stock is trading at a level that may not be fully supported by its current capital efficiency and earnings performance.
Debt and Shareholding Structure
Chemfab Alkalis maintains a low average debt-to-equity ratio of 0.10 times, reflecting a conservative approach to leverage. Despite the company’s size, domestic mutual funds hold a modest stake of only 0.25%. This limited institutional holding may reflect a cautious stance given the company’s recent financial trajectory and valuation considerations.
Market Comparison and Sector Performance
Within the commodity chemicals sector, Chemfab Alkalis has underperformed relative to its peers and the broader market indices. While the BSE500 index has generated a marginal return of 0.27% over the past year, Chemfab Alkalis’ stock has declined sharply. The sector itself has seen mixed performance, with some companies maintaining steadier earnings and valuations.
Is Chemfab Alkalis your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Summary of Key Metrics
The stock’s recent price action, hitting Rs.451.6, marks a significant low point in a year characterised by declining sales and profitability. The company’s financial results show a consistent pattern of contraction in net sales and earnings, with profitability metrics remaining subdued. Valuation ratios suggest the stock is trading at a premium relative to its capital returns and peer group averages. Meanwhile, the broader market and sector indices have shown relative strength, highlighting the divergence in performance.
Conclusion
Chemfab Alkalis’ fall to its 52-week low reflects a combination of subdued financial results and valuation considerations amid a market environment that has otherwise shown resilience. The stock’s position below all major moving averages and its significant underperformance relative to the Sensex and sector peers underscore the challenges faced by the company over the past year.
Only ₹14,999 - Get MojoOne + Stock of the Week for 2 Years PLUS 6 Months FREE Claim 83% OFF →
